Filter By:
Prostate Specific Antigen Doubling Time (PSADT) has been shown to be a better prognostic tool in determining prostate cancer specific mortality. Dr. Martin Gleave of the Vancouver Prostate Cancer Centre discusses his findings as a guide for patients and physicians.
by:vhsimons | 257 views
When primary therapy in the treatment of prostate cancer fails, hormonal therapy is normally the next step in managing the disease. However much discussion has centered around whether intermittent androgen deprivation (IAD) or continuous androgen deprivation (CAD) therapy is best for overall survival. Dr. Maha Hussain provides a commentary ba...
by:vhsimons | 130 views
Louis M. Weiner, MD, explains that checkpoint inhibitors represent a promising treatment option for essentially all types of cancer, since a tumor cannot form without first overcoming the immune system. To view more from this discussion, visit http://www.o...
by:onclivetv | 732 views
Jean DiCarlo-Wagner is a vibrant Stage III Colorectal Cancer Survivor turned yoga instructor. In this video, she shares her gift of teaching Yoga to cancer survivors at National Women's Survivor Convention. Jean invites you to take your shoes off, enjoy some monkey-see, monkey-do yoga and relax. Sh...
by:SayYEStoHOPE | 1527 views
Daniel P. Petrylak, MD, director, Prostate and GU Medical Oncology, Yale Cancer Center, discusses the results of a phase II trial that examined prostate specific membrane antigen antibody drug conjugate (PSMA ADC) in taxane-treated metastatic castration-resi​stant prostate cancer (mCRPC) patients.
by:onclivetv | 262 views
Held annually in South Florida every January, The Symposium on Clinical Interventional Oncology (CIO) features a concentrated 2-day program renowned for its originality, patient-care focus and dynamic learning format. CIO focuses on highlighting the most viable and sought-after treatments in interventional oncology while shining a spotlight on cur...
by:InterventionalOncology | 412 views
E. David Crawford, MD, professor, Urologic and Radiation Oncology, head, Section of Urologic Oncology, University of Colorado at Denver, discusses a study presented at the 2014 AUA Annual Meeting that analyzed intermittent androgen deprivation with degarelix.
by:onclivetv | 466 views
Dr. Samadi has joined Lenox Hill Hospital in New York as Chair of Urology. Dr. Samadi is a pioneer in the field of robotic prostatectomy and developed the SMART (Samadi Modern Advanced Robotic Technique) surgery.
by:Roboticoncology | 264 views
There's just no substitute for patients stepping into an active role in advancing research. In this video, Dr. Larry Karsh, Director of Clinical Research at the Urology Center of Colorado, explains the important role patients play in clinical research to advance treatment options for prostate cancer...
by:patientpower | 2568 views
Download from iTunes: https://itun.... Blue light cystoscopy (Cysview) reveals more than traditional white light cystoscopy since the bladder cancer cells that become visible in blue light may be invisible with traditional whi...
by:mdanderson | 2101 views

Top Tags

Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Different type of MD 
Other oncology Professional 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.

username:   password: remember me

Sign In

Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)